Fusing of the science of behavioural economics with real-world applications

3B BlackBio provides a wide range of products and services in molecular testing

Robotic rehabilitation solutions for patients suffering from a variety of neurological diseases

XEPTAGEN provides diagnostic solutions

XEPTAGEN SpA is engaged in the discovery and validation of novel molecular markers in order to produce innovative diagnostic kits for cancer (lat. Carcinoma) early detection, monitoring, and evaluation of response to therapy. By exploiting the natural immune response to early-stage cancer and the proprietary platform technology Combinatorial Proteomic®, XEPTAGEN has discovered predictive, prognostic and early response tumour markers that lead to earlier and much more accurate detection of developing carcinomas. The company's mission is to include creating innovative tools that improve the clinical management of patients with liver, colorectal and prostate cancers (lat. Prostate Carcinoma).

40 days ago

Everwell: a user-centric technology for healthcare programs

Everwell Health Solutions is a Bangalore-based company that innovates, designs, builds and deploys user-centric technology for healthcare programs across the world. The company spun out of Microsoft Research India in 2015 by co-founders Andrew Cross and Bill Thies. Joined by Nakull Gupta, they began building a team in 2016 to champion their flagship work in digital adherence monitoring, 99DOTS, out of research and into large scale uptake in India. The company’s Everwell Hub is a comprehensive, integrated platform for adherence and patient management. Health care staff can log into a single portal to register and follow up with patients, whose adherence reports from any of its integrated technologies appear side-by-side including 99DOTS, evriMED devices, and VOT.

45 days ago

Diagnosing prostate cancer quickly and safely

Distinguishing between benign and malignant prostate tissue is difficult. A new device facilitates the diagnosis for doctors: Through visual analysis, they can reliably determine if they are dealing with carcinoma within a minute-and-a-half. Fraunhofer researchers have presented the prototype at the COMPAMED trade fair in Düsseldorf. Generally. doctors take a biopsy of prostate tissue from the patient to find out if it is carcinoma of the prostate – or a benign tissue change. In doing so, they insert a small needle into the prostate, using ultrasound images to assist with navigation. From the sample taken in this way, laboratory employees fabricate wafer-thin tissue sections – a laborious job that takes at least a day. Then, the tissue sections are forwarded to a pathologist, who examines them under the microscope. Even for experienced physicians, though, it is often difficult to distinguish between benign and malignant tissue.

47 days ago

Avisa Pharma detects and monitors pulmonary infections

Docturnal detects tuberculosis in a non-invasive way

Thirty Madison: rebuilding the healthcare experience for consumers

Joylux: empowering women to live their best lives

Joylux, a Seattle-based company, creates innovative health solutions targeting the enormous, but underserved female intimate care market. Joylux provides customers with LED-focused medical devices that are transforming women's pelvic floor health. Available exclusively in international markets outside of the U.S., vSculpt is the world's first home-use vaginal rejuvenation device using light-energy, gentle heat and sonic technology to treat the vaginal tissue and pelvic floor muscles. vSculpt is cleared as a Class II OTC Medical Device for the treatment of incontinence, vaginal dryness and pelvic pain in Canada, Europe, Australia and other parts of the world.

51 days ago

A new way to identify clinically meaningful changes in the DNA of cancer tumors

TOMA Biosciences, Inc. is a genomics company that provides physicians information to optimize treatment for cancer (lat. Carcinoma) patients. TOMA’s proprietary sequencing solution turns the latest next generation sequencing (NGS) technology into a powerful digital tool to detect the most clinically meaningful changes in a patient’s tumor DNA. Physicians use this important data to optimize treatment for their patients. TOMA is a commercial stage private venture baked company headquartered in Foster City, California.  TOMA has commercially launched TOMA OS-SeqTM Cancer Assay to help laboratories and researchers uncover clinically meaningful genomic changes in tumors, including many missed by other methods.

51 days ago

Ro: Changing lives by changing healthcare

Roman, a telehealth spinoff that sells erectile dysfunction pills online, has raised $88 million to tackle another common health problem: smoking. It was founded in 2017 by CEO Zachariah Reitano, Saman Rahmanian and Rob Schutz. It raised $3 million in 2017 to sell erectile dysfunction medication over the internet. At Ro, doctors, pharmacists and engineers are working together to reinvent the way the healthcare system works. By tearing down the walls and bringing providers and patients together in one place, the researchers at Ro are making it easier and more affordable for millions of people to get personalized treatment, get healthy and get back to living the lives they dream about.

51 days ago

Cookies help us deliver our Services. By using our website or clicking I agree, you agree to our use of cookies. Learn more about our cookie and privacy policy.